JD Health International Inc. (JDHIF)

OTCMKTS · Delayed Price · Currency is USD
5.85
0.00 (0.00%)
Jun 1, 2026, 4:00 PM EST
Market Cap16.31B +4.6%
Revenue (ttm)10.50B +26.3%
Net Income768.53M +29.2%
EPS0.24 +27.3%
Shares Out n/a
PE Ratio21.22
Forward PE15.78
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Open5.85
Previous Close5.85
Day's Range5.85 - 5.85
52-Week Range5.10 - 8.75
Beta1.13
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About JD Health International

JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People’s Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. The company also offers home care services, including wound care, blood tests and diagnostics, post-operative care, and medical escort; online medical in... [Read more]

Sector Healthcare
Founded 2014
Employees 5,263
Stock Exchange OTCMKTS
Ticker Symbol JDHIF

Financial Performance

In 2025, JD Health International's revenue was 73.44 billion, an increase of 26.28% compared to the previous year's 58.16 billion. Earnings were 5.38 billion, an increase of 29.16%.

Financial numbers in CNY Financial Statements

News

JD Health International Earnings Call Transcript: H2 2025

Revenue grew 26.3% year-over-year to RMB 73.4 billion, with non-IFRS profit up 36.3% and gross margin at 24.8%. Strategic partnerships, AI-driven services, and expanded product offerings fueled growth, while the company sees significant market potential ahead.

3 months ago - Transcripts

JD Health International Earnings release: H2 2025

JD Health International released its H2 2025 earnings on March 5, 2026, summarizing the period's financial results.

3 months ago - Filings

JD Health International Annual report: H2 2025

JD Health International has published its H2 2025 annual report on March 5, 2026.

3 months ago - Filings

JD Health International Earnings Call Transcript: H1 2025

Revenue grew 24.5% year-over-year to RMB 35.3 billion, with non-GAAP net profit up 35%. AI-driven services and omnichannel retail expansion fueled user growth to 200 million, while gross margin and operating efficiency improved.

10 months ago - Transcripts

JD Health International Quarterly report: H1 2025

JD Health International has published its H1 2025 quarterly earnings report on August 14, 2025.

10 months ago - Filings

JD Health International Earnings release: H1 2025

JD Health International released its H1 2025 earnings on August 14, 2025, summarizing the period's financial results.

10 months ago - Filings

‘The China equity trade is back' and here are the stocks to pick, says SocGen

Early futures action suggest the S&P 500 SPX will open a fraction shy of the fresh record close hit this week.

2 years ago - Market Watch